Dysphoria did not significantly improve in either group, while sexual desire and function decreased at six months in both
💀
A community for transfeminine people and experiences.
This is a supportive community for all transfeminine or questioning people. Anyone is welcome to participate in this community but disrupting the safety of this space for trans feminine people is unacceptable and will result in moderator action.
Debate surrounding transgender rights or acceptance will result in an immediate ban.
This community is supportive of DIY HRT. Unsolicited medical advice or caution being given to people on DIY will result in moderator action.
Posters may express that they are looking for responses and support from groups with certain experiences (eg. trans people, trans people with supportive parents, trans parents.). Please respect those requests and be mindful that your experience may differ from others here.
To make such a request, at the start of the body of your post, not in the title, the first line should look like the this: [Requesting Engagement from _________]
Some helpful links:
Support Hotlines:
Dysphoria did not significantly improve in either group, while sexual desire and function decreased at six months in both
💀
I think this conclusion is incredibly naïve given the dramatically increased bioavailability and significantly decreased side effects that sublingual administration has over oral estradiol. Flooding the liver through oral administration results in strain that is significantly reduced by sublingual administration, and the increased bioavailability alone accounted for comparable testosterone suppression without an anti-androgen at the same daily dosage. So on top of the decrease in liver damage by moving away from oral administration, this approach also does not account for the side effects of the anti-androgen. The miniscule sample size doesn't do any favors to this study, either. The supposed "alarming excursions of serum estradiol" is solved simply by adjusting the dosage and spreading it out into more frequent doses throughout the day. It seems they did split the dosage into 4 doses for sublingual administration, but they are providing the same daily dosage despite significantly increased bioavailability of the sublingual route (which also accounts for the testosterone suppression). Additionally, a dosage of only 2mg of estradiol daily via oral administration is quite low for trans women.
I have a lot of problems with the conclusions of this study.
I'd like to link to a much more complete analysis of the sublingual route of administration for estradiol that analyzes a wide variety of sources (including the one linked in this post) for those interested in a more accurate picture of the benefits and shortcomings of sublingual administration:
An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People